In this GEN webinar, our expert speakers, Erin Redman, PhD, and Ruben Cageling, will describe how the ZipChip microfluidic CE-MS technology enables rapid early-stage clone screening for biotherapeutics development.
In this GEN webinar, our speaker John Renger, PhD, CSO at Cerevel Therapeutics, discusses preclinical markers used in assays relevant to neurodegenerative disease processes, including the evaluation of autophagy and mitophagy using methods such as immunohistochemistry, western blotting, ELISA-like assays, high content analysis, and other platforms.
In this GEN webinar, Justin Ichida, PhD, an expert in stem cell biology and regenerative medicine at the Keck School of Medicine, USC discusses using organoids to clear up the causes of neuronal damage following TBIs and ways of mitigating injury risks.
In this GEN webinar, Aaron Rose, PhD, explores how biological therapeutics are reshaping the traditional drug development process and why humanized models are essential for advancing biologics programs.
Join this keynote discussion on the latest advancements, new norms, emerging trends and breakthrough topics from AACR by our expert panelists, offering clarity on the current landscape, with a deep dive into the latest advancements on how spatial biology is shaping precision medicine and cancer research. Hear expert perspectives on how the global research community has united in an unprecedented collaboration.
In this GEN webinar, Scott Alderucci will discuss ways of leveraging new technologies and experimental design for an optimized, tailored approach to mRNA therapy development.
In this GEN webinar, our speakers Ettai Markovits, MD, and Arutha Kulasinghe, PhD, will discuss how AI-based spatial analysis of mIF data can accelerate the discovery of clinically relevant biomarkers that can predict response and resistance mechanisms to immunotherapy.
In this GEN webinar, our panelists Jim Huggett, PhD, and Boshen Gao will introduce the dPCR workflow and discuss this technology’s advantages over traditional qPCR including higher precision, more flexibility, increased sensitivity, and true absolute quantification.
In this webinar, Dr. Kopcho from InDevr will demonstrate the flexibility of the VaxArray platform through a variety of case studies and customer examples that include the utility of InDevR’s off-the-shelf kits for influenza vaccines and pneumococcal conjugate vaccines, as well as a variety of custom kits.
In this GEN webinar, two experts, Prashant Vaidyanathan, PhD, and Rob Brown, PhD, will discuss advancements in configurable lab workflows, AI ChatGPT, and next-generation lab informatics that are enabling novel discoveries in cell and gene therapy.
In this GEN keynote webinar, Mattia Gerli, PhD, and Paolo De Coppi, MD, (University College London, Institute of Child Health) will reveal how their team achieved this landmark in organoid research.
On this GEN webinar, SomaLogic CSO Nebojsa Janjic, PhD, will discuss the need for a reliable blood-based screening method capable of detecting cancers earlier.
In thi’s GEN webinar, Valo Therapeutics’ Senior Scientist, Dr. Joseph Ndika, will describe a workflow that leverages Valo Therapeutics’ innovative microfluidics-based immunoaffinity platform in combination with Bruker’s ultra-high sensitivity mass spectrometry, to identify tumor-specific HLA Class I antigens from as few as 10,000 cells.
In this GEN webinar, our expert speakers will discuss how QSP modeling improves early feasibility assessment, rational therapy design, and clinical development of cell and gene therapies.
In this GEN webinar, Enable Medicine’s Alex Trevino, PhD, discusses how AI-powered algorithms within the Enable platform facilitate comprehensive data storage, annotation, analysis, and search.
